According to preliminary data from the Centers for Medicare and Medicaid Services (CMS), Humana Inc. (NYSE:HUM) faces a substantial drop in its Medicare Advantage (MA) Star Ratings for 2025.
The data available in the CMS Plan Finder as of October 1, 2024, reveals that only 25% of Humana’s members are enrolled in plans rated four stars and above, a sharp decline from 94% in 2024.
The decrease is primarily driven by contract H5216, which holds around 45% of Humana’s MA membership and 90% of its employer group waiver plan (Group MA) membership.
Also Read: FTC Investigation Uncovers Anti-Competitive Practices By Handful Of Pharmacy Benefit Managers, Including CVS Health, UnitedHealth.
H5216’s rating dropped to 3.5 stars ...
